http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0105173-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
filingDate 2001-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4b2a927b2a4acd7d4debbc3741cfa52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bb3abe55778ad6ec698651ded393643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6781f7303abb868ec6f36a49c11312b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90aaad38faf842bd9d7e4ff9fba3734c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65b2d3086330e059a56d7742ec3345ee
publicationDate 2003-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-0105173-A2
titleOfInvention Method of administration and preparation for emergency contraception
abstract FIELD OF THE INVENTION The present invention relates to a method of administering an emergency contraceptive, to the use of a composition for that purpose, to a preparation of levonorgestrel for such purpose, and to a method for the preparation of such a composition. For emergency contraception according to the invention, the levonorgestrel active ingredient is administered within a single dosage unit containing 1.5 <0.2 mg of levonorgestrel active ingredient within 72 hours of acoustic injury. The compositions according to the invention contain, per unit dosage form, only 1.5 <0.2 mg of levonorgestrel as active ingredient in excipients, fillers, diluents, flavors, stabilizers and formulation aids which are conventional in the preparation of pharmaceutical compositions. SHE
priorityDate 2001-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506267

Total number of triples: 25.